Language
English
Publication Date
11-4-2024
Journal
Journal of the Pediatric Infectious Diseases Society
DOI
10.1093/jpids/piae080
PMID
39149792
PMCID
PMC12106274
PubMedCentral® Posted Date
8-16-2024
PubMedCentral® Full Text Version
Post-print
Abstract
Post-artesunate delayed hemolysis (PADH) occurred in 6 of 24 children treated with artesunate for severe malaria in the United States; however, severe hemolysis requiring hospitalization or transfusion was rare. In children in the United States treated with artesunate, counseling, and symptom monitoring may be preferred to weekly laboratory surveillance for PADH.
Keywords
Humans, Artesunate, Hemolysis, Antimalarials, United States, Child, Preschool, Child, Male, Female, Infant, Malaria, adverse drug reaction, artesunate, hemolytic anemia, malaria, pediatric, post-artesunate delayed hemolysis
Published Open-Access
yes
Recommended Citation
Sundararaman, Sesh A; Hanze Villavicencio, Karen L; Roper, Brianne; et al., "Post-Artesunate Delayed Hemolysis in Pediatric Malaria Patients in the United States" (2024). Faculty and Staff Publications. 4713.
https://digitalcommons.library.tmc.edu/baylor_docs/4713